145 related articles for article (PubMed ID: 7632809)
1. Comparison of scoring systems in primary myelodysplastic syndromes.
Maschek H; Gutzmer R; Choritz H; Georgii A
Ann Hematol; 1995 Jun; 70(6):301-8. PubMed ID: 7632809
[TBL] [Abstract][Full Text] [Related]
2. Life expectancy in primary myelodysplastic syndromes: a prognostic score based upon histopathology from bone marrow biopsies of 569 patients.
Maschek H; Gutzmer R; Choritz H; Georgii A
Eur J Haematol; 1994 Nov; 53(5):280-7. PubMed ID: 7813708
[TBL] [Abstract][Full Text] [Related]
3. Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes.
Varma N; Varma S
Indian J Pathol Microbiol; 2008; 51(1):97-101. PubMed ID: 18417875
[TBL] [Abstract][Full Text] [Related]
4. [Scoring analysis on prognosis of 63 patients with melodysplastic syndrome].
Wei J; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):305-11. PubMed ID: 18426654
[TBL] [Abstract][Full Text] [Related]
5. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.
Aul C; Gattermann N; Germing U; Runde V; Heyll A; Schneider W
Leukemia; 1994 Nov; 8(11):1906-13. PubMed ID: 7967735
[TBL] [Abstract][Full Text] [Related]
7. Long-term survivors in myelodysplastic syndromes: clinical and biological characteristics.
Marisavljević D; Rolović Z; Bosković D; Colović M
Med Oncol; 2004; 21(4):333-8. PubMed ID: 15579917
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
[TBL] [Abstract][Full Text] [Related]
9. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
11. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
12. [The International Prognostic Scoring System for primary myelodysplastic syndrome].
Sisková M; Dohnalová A; Neuwirtová R; Pĕnicková J; Karban J; Cmunt E
Sb Lek; 2002; 103(3):333-8. PubMed ID: 12688177
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis and AML development in patients with de novo myelodysplastic syndromes: comparison of six different prognostic scoring systems.
Sperr WR; Wimazal F; Kundi M; Fonatsch C; Thalhammer-Scherrer R; Schernthaner GH; Schwarzinger I; Haas OA; Geissler K; Lechner K; Valent P
Ann Hematol; 2001 May; 80(5):272-7. PubMed ID: 11446729
[TBL] [Abstract][Full Text] [Related]
14. The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution.
Zhao WL; Xu L; Wu W; Yan H; Tang W; Hu J; Chen Y; Li JM; Zeng XY; Xiong SM; Shen ZX; Chen Z; Wang ZY; Chen SJ
Hematol J; 2002; 3(3):137-44. PubMed ID: 12111649
[TBL] [Abstract][Full Text] [Related]
15. Improved risk stratification by the integration of the revised international prognostic scoring system with the myelodysplastic syndromes comorbidity index.
van Spronsen MF; Ossenkoppele GJ; Holman R; van de Loosdrecht AA
Eur J Cancer; 2014 Dec; 50(18):3198-205. PubMed ID: 25454415
[TBL] [Abstract][Full Text] [Related]
16. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis.
Maschek H; Kaloutsi V; Rodriguez-Kaiser M; Werner M; Choritz H; Mainzer K; Dietzfelbinger M; Georgii A
Ann Hematol; 1993 Mar; 66(3):117-22. PubMed ID: 8471656
[TBL] [Abstract][Full Text] [Related]
17. Long-term survivors in myelodysplastic syndromes: a report on 63 cases and comparison with short and intermediate survivors.
Wattel E; Hecquet B; Grahek D; Hebbar M; Morel P; Lai JL; Bauters F; Fenaux P
Leuk Res; 1993 Sep; 17(9):733-9. PubMed ID: 8371573
[TBL] [Abstract][Full Text] [Related]
18. [Prediction of survival in myelodysplastic syndrome. Analysis of 2 scoring systems with prognostic value].
Sanz GF; Sanz MA; Vallespí T; Cañizo MC; García S; Torrabadella M; San Miguel JF; Irriguible D
Sangre (Barc); 1989 Feb; 34(1):41-6. PubMed ID: 2711284
[TBL] [Abstract][Full Text] [Related]
19. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome.
Lee JH; Lee JH; Shin YR; Lee JS; Kim WK; Chi HS; Park CJ; Seo EJ; Lee KH
Leukemia; 2003 Feb; 17(2):305-13. PubMed ID: 12592327
[TBL] [Abstract][Full Text] [Related]
20. Prognostic evaluation of ALIP and CD34 immunostaining in IPSS-R subgroups of myelodysplastic syndromes.
Xiong B; Nie Y; Tang Z; Xue M; Zuo X
Pathology; 2017 Aug; 49(5):526-533. PubMed ID: 28669578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]